Physician profile
Jared S Friedman
NPI 1316904147
$584.88
in general payments reported to CMS, 2019-2025
8 companies · $99.57 in 2025
The $99.57 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.84 · 2020: $18.06 · 2021: $90.97 · 2022: $48.42 · 2023: $109 · 2024: $204 · 2025: $99.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $178.78 | 2020-2023 | |
| Kerecis Limited | $138.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Regeneron Healthcare Solutions, INC. | $130.80 | 2023-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $40.92 | 2024 | Vtama |
| Pfizer INC. | $34.83 | 2019-2022 | |
| Botanix Sb INC | $23.24 | 2025 | Sofdra |
| Convatec INC. | $20.36 | 2025 | |
| Arcutis Biotherapeutics, INC. | $17.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.